Morgan Stanley’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.52B | Sell |
19,444,871
-1,272,158
| -6% | -$103M | 0.08% | 217 |
|
|
2026
Q1 | $1.8B | Buy |
20,717,029
+494,454
| +2% | +$47.4M | 0.11% | 164 |
|
|
2025
Q4 | $1.94B | Sell |
20,222,575
-9,674
| -0% | -$940K | 0.12% | 157 |
|
|
2025
Q3 | $1.93B | Buy |
20,232,249
+1,207,610
| +6% | +$111M | 0.12% | 152 |
|
|
2025
Q2 | $1.66B | Sell |
19,024,639
-403,255
| -2% | -$34.2M | 0.11% | 167 |
|
|
2025
Q1 | $1.75B | Buy |
19,427,894
+489,528
| +3% | +$43.8M | 0.12% | 146 |
|
|
2024
Q4 | $1.51B | Sell |
18,938,366
-4,561,777
| -19% | -$395M | 0.11% | 170 |
|
|
2024
Q3 | $2.12B | Sell |
23,500,143
-4,769,328
| -17% | -$401M | 0.15% | 120 |
|
|
2024
Q2 | $2.23B | Buy |
28,269,471
+1,266,542
| +5% | +$104M | 0.17% | 104 |
|
|
2024
Q1 | $2.35B | Buy |
27,002,929
+3,721,019
| +16% | +$318M | 0.19% | 95 |
|
|
2023
Q4 | $1.92B | Sell |
23,281,910
-495,898
| -2% | -$37.8M | 0.17% | 114 |
|
|
2023
Q3 | $1.86B | Buy |
23,777,808
+1,994,123
| +9% | +$167M | 0.19% | 106 |
|
|
2023
Q2 | $1.92B | Buy |
21,783,685
+3,055,462
| +16% | +$263M | 0.19% | 104 |
|
|
2023
Q1 | $1.51B | Buy |
18,728,223
+801,053
| +4% | +$65.3M | 0.16% | 128 |
|
|
2022
Q4 | $1.39B | Sell |
17,927,170
-82,726
| -0.5% | -$6.7M | 0.16% | 134 |
|
|
2022
Q3 | $1.45B | Buy |
18,009,896
+522,669
| +3% | +$47M | 0.2% | 103 |
|
|
2022
Q2 | $1.57B | Buy |
17,487,227
+2,527,982
| +17% | +$256M | 0.2% | 103 |
|
|
2022
Q1 | $1.66B | Sell |
14,959,245
-8,195
| -0.1% | -$866K | 0.22% | 101 |
|
|
2021
Q4 | $1.55B | Buy |
14,967,440
+1,419,780
| +10% | +$164M | 0.19% | 119 |
|
|
2021
Q3 | $1.7B | Buy |
13,547,660
+547,223
| +4% | +$70.8M | 0.23% | 100 |
|
|
2021
Q2 | $1.61B | Buy |
13,000,437
+981,186
| +8% | +$123M | 0.21% | 114 |
|
|
2021
Q1 | $1.42B | Buy |
12,019,251
+458,766
| +4% | +$53.8M | 0.21% | 116 |
|
|
2020
Q4 | $1.35B | Buy |
11,560,485
+1,221,333
| +12% | +$134M | 0.21% | 111 |
|
|
2020
Q3 | $1.07B | Buy |
10,339,152
+659,510
| +7% | +$66.2M | 0.21% | 115 |
|
|
2020
Q2 | $888M | Buy |
9,679,642
+1,331,835
| +16% | +$128M | 0.2% | 120 |
|
|
2020
Q1 | $753M | Buy |
8,347,807
+741,368
| +10% | +$78.9M | 0.2% | 116 |
|
|
2019
Q4 | $863M | Buy |
7,606,439
+273,552
| +4% | +$30M | 0.2% | 113 |
|
|
2019
Q3 | $796M | Sell |
7,332,887
-328,065
| -4% | -$34.2M | 0.21% | 107 |
|
|
2019
Q2 | $746M | Buy |
7,660,952
+453,392
| +6% | +$41.4M | 0.2% | 113 |
|
|
2019
Q1 | $656M | Sell |
7,207,560
-1,520,330
| -17% | -$136M | 0.19% | 122 |
|
|
2018
Q4 | $794M | Buy |
8,727,890
+621,900
| +8% | +$58.1M | 0.24% | 96 |
|
|
2018
Q3 | $797M | Sell |
8,105,990
-223,855
| -3% | -$20.7M | 0.2% | 106 |
|
|
2018
Q2 | $713M | Sell |
8,329,845
-285,913
| -3% | -$23.9M | 0.19% | 112 |
|
|
2018
Q1 | $691M | Sell |
8,615,758
-86,422
| -1% | -$7.13M | 0.19% | 103 |
|
|
2017
Q4 | $703M | Sell |
8,702,180
-561,779
| -6% | -$45M | 0.19% | 111 |
|
|
2017
Q3 | $720M | Buy |
9,263,959
+1,603,573
| +21% | +$133M | 0.22% | 102 |
|
|
2017
Q2 | $680M | Sell |
7,660,386
-3,912,327
| -34% | -$330M | 0.21% | 104 |
|
|
2017
Q1 | $932M | Sell |
11,572,713
-373,900
| -3% | -$29.2M | 0.29% | 71 |
|
|
2016
Q4 | $851M | Buy |
11,946,613
+1,543,454
| +15% | +$121M | 0.28% | 66 |
|
|
2016
Q3 | $899M | Buy |
10,403,159
+29,632
| +0.3% | +$2.58M | 0.31% | 58 |
|
|
2016
Q2 | $900M | Sell |
10,373,527
-913,882
| -8% | -$73.9M | 0.33% | 50 |
|
|
2016
Q1 | $847M | Buy |
11,287,409
+2,191,811
| +24% | +$165M | 0.33% | 50 |
|
|
2015
Q4 | $700M | Buy |
9,095,598
+979,589
| +12% | +$73.7M | 0.25% | 85 |
|
|
2015
Q3 | $543M | Buy |
8,116,009
+1,090,458
| +16% | +$80.3M | 0.2% | 110 |
|
|
2015
Q2 | $521M | Buy |
7,025,551
+1,548,936
| +28% | +$118M | 0.18% | 136 |
|
|
2015
Q1 | $427M | Buy |
5,476,615
+1,646,989
| +43% | +$125M | 0.16% | 152 |
|
|
2014
Q4 | $277M | Buy |
3,829,626
+2,527
| +0.1% | +$176K | 0.1% | 231 |
|
|
2014
Q3 | $237M | Buy |
3,827,099
+650,842
| +20% | +$41.4M | 0.09% | 244 |
|
|
2014
Q2 | $203M | Buy |
3,176,257
+139,017
| +5% | +$8.44M | 0.08% | 276 |
|
|
2014
Q1 | $187M | Sell |
3,037,240
-1,107,206
| -27% | -$64.5M | 0.08% | 289 |
|
|
2013
Q4 | $238M | Buy |
4,144,446
+1,339,198
| +48% | +$75.9M | 0.1% | 225 |
|
|
2013
Q3 | $149M | Sell |
2,805,248
-524,341
| -16% | -$28.2M | 0.07% | 324 |
|
|
2013
Q2 | $171M | Buy |
+3,329,589
| New | +$165M | 0.09% | 265 |
|
Other funds holding MDT
Morgan Stanley's MDT Position: Q2 2026 in Review
Morgan Stanley reduced its Medtronic (MDT) stake by 6.1% in Q2 2026, selling an estimated $103M and leaving 19,444,871 shares worth $1.52B. The position accounts for 0.08% of the portfolio, ranked #217.
Morgan Stanley first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.35B in Q1 2024. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Morgan Stanley held 19,444,871 shares of Medtronic worth $1.52B as of Q2 2026.
- Morgan Stanley sold 1,272,158 Medtronic shares in Q2 2026, an estimated $103M.
- Medtronic made up 0.08% of Morgan Stanley's portfolio in Q2 2026, its #217 holding.
- Morgan Stanley first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
- Morgan Stanley's Medtronic position peaked at $2.35B in Q1 2024.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.